EUVIMEDEUVIMED entdecken
Crossref

An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy

Jin-Feng Yu, Yu Wen, Ming Li iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202401061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Jin-Feng Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, Central South University, Changsha, Hunan, 410083, China. Hauptthemen laut MEDLINE: Mitochondria, Photochemotherapy, Immunotherapy, Optical Imaging. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Science and Technology of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy targeting mitochondria represents a promising therapeutic strategy for fighting diverse types of cancers. However, the currently available photosensitizers (PSs) suffer from insufficient therapeutic potency, limited mitochondria delivery efficiency, and the inability to treat invisible metastatic distal cancers. Herein, an active self‐mitochondria‐targeting heptapeptide cyanine (HCy) immunomodulator (I 2 HCy‐QAP) is reported for near‐infrared II (NIR‐II) fluorescence imaging‐guided photodynamic immunotherapy of primary and distal metastatic cancers. The I 2 HCy‐QAP is designed by introducing a quaternary ammonium salt with a phenethylamine skeleton (QAP) into the iodinated HCy photosensitizer. The I 2 HCy‐QAP can precisely target mitochondria due to the lipophilic cationic QAP unit, present strong NIR‐II fluorescence tail emission, and effectively generate singlet oxygen 1 O 2 under NIR laser irradiation, thereby inducing mitochondria‐targeted damages and eliciting strong systemic immunogenic cell death immune responses. The combination of the I 2 HCy‐QAP‐mediated photodynamic immunotherapy with anti‐programmed death‐1 antibody therapy achieves remarkable therapeutic efficacy against both primary and distal metastatic cancers with significant inhibition of lung metastasis in a triple‐negative breast cancer model. This work provides a new concept for designing high‐performance NIR emissive cyanine immunomodulators for NIR‐II fluorescence‐guided photodynamic immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaPhotochemotherapyImmunotherapyOptical ImagingCarbocyaninesAnimalsMiceFemaleHumansCell Line, TumorPhotosensitizing AgentsImmunologic FactorsMice, Inbred BALB CInfrared Rays

Stichwörter der Autor:innen

NIR‐II fluorescence imagingcyanine photosensitizersimmune responsesmitochondria‐targetingphotodynamic therapy

Substanzen

CarbocyaninesPhotosensitizing AgentsImmunologic Factors

Autor:innen und Institutionen

  • School of Materials Science and Engineering, Central South University, Changsha, Hunan, 410083, China.
  • Furong Laboratory, Central South University, Changsha, Hunan, 410008, China.

ORCID-Profile: Ming Li

Förderung

  • National Natural Science Foundation of China
  • Department of Science and Technology of Hunan Province

Zitieren

APA

Yu, J. F., Wen, Y., & Li, M. (2024). An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401061

Vancouver

Yu JF, Wen Y, Li M. An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401061

BibTeX
@article{Yu2024,
  author = {Yu, Jin-Feng and Wen, Yu and Li, Ming},
  title = {An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202401061}
}
Kostenlos starten →